Nanotechnology

Apps Associates Honored in CRN’s MSP 500 List for Excellence in Managed Services

Retrieved on: 
Tuesday, February 13, 2024

Apps Associates , an acclaimed global leader in enterprise application services, announced today that CRN® , a brand of The Channel Company , has named Apps Associates to its Managed Service Provider (MSP) 500 list in the Pioneer 250 category for 2024.

Key Points: 
  • Apps Associates , an acclaimed global leader in enterprise application services, announced today that CRN® , a brand of The Channel Company , has named Apps Associates to its Managed Service Provider (MSP) 500 list in the Pioneer 250 category for 2024.
  • The MSP 500 list compiled by CRN serves as a comprehensive guide to identifying and recognizing the top Managed Service Providers (MSPs) in North America.
  • Apps Associates is honored for its AppsAssurance Managed Services , enabling organizations to prioritize their core functions by simplifying technology management for applications and infrastructure.
  • Our AppsAssurance Managed Services go beyond support; they are a cornerstone for innovation and operational efficiency," said Adrian King, CEO of Apps Associates.

Bruker Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, February 13, 2024

Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2023.

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2023.
  • Q4 2023 Bruker Scientific Instruments (BSI) revenues of $783.6 million increased 20.2% yoy, with organic revenue growth of 15.5%.
  • Q4 2023 Bruker Energy & Supercon Technologies (BEST) revenues of $75.2 million increased 27.7% yoy, with organic revenue growth, net of intercompany eliminations, of 20.3%.
  • [1] In Q4 2023, Bruker recorded a GAAP gain of $144.1 million, or $0.99 per share, in connection with the PhenomeX acquisition, which closed on October 2, 2023.

Nicoya Expands Into India With Appointment of Medispec as Exclusive Distributor

Retrieved on: 
Tuesday, February 13, 2024

Nicoya®, a pioneering life science instrument company specializing in innovative biosensor technology, is pleased to announce the appointment of Medispec as its exclusive distributor in India.

Key Points: 
  • Nicoya®, a pioneering life science instrument company specializing in innovative biosensor technology, is pleased to announce the appointment of Medispec as its exclusive distributor in India.
  • Nicoya is renowned for its state-of-the-art Alto™ and OpenSPR® platforms that are designed to accelerate biomolecular interaction studies and lead screening during drug discovery.
  • With a mission to improve human life by helping scientists succeed, Nicoya is excited to collaborate with Medispec to bring its groundbreaking technologies to the Indian market as demand grows.
  • Their dedication to supporting scientific advancements aligns seamlessly with Nicoya's vision, making them the ideal partner to represent Nicoya in India.

MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation

Retrieved on: 
Tuesday, February 13, 2024

LONDON, Feb. 13, 2024 /PRNewswire/ -- MGC Pharmaceuticals Ltd (LSE: MXC), (OTC: MGCLF), (ASX: MXC)  Rebrands as Argent BioPharma in Strategic TransformationMarking a significant milestone in its evolutionary journey, MGC Pharma has officially announced its rebranding to Argent BioPharma, pending approval from its shareholders. This rebranding is the culmination of an extensive restructuring, incorporating significant American capital and operational revisions. Poised for growth, Argent BioPharma is now set to emerge as a key player in the biopharmaceutical industry, leveraging cutting-edge advancements in Polypharmacology and Nanotechnology. With its presence on both the London Stock Exchange and the Australian Stock Exchange, Argent BioPharma is well-positioned to make substantial contributions to enhancing medical treatment accessibility.

Key Points: 
  • LONDON, Feb. 13, 2024 /PRNewswire/ -- MGC Pharmaceuticals Ltd (LSE: MXC), (OTC: MGCLF), (ASX: MXC)  Rebrands as Argent BioPharma in Strategic Transformation
    Marking a significant milestone in its evolutionary journey, MGC Pharma has officially announced its rebranding to Argent BioPharma, pending approval from its shareholders.
  • Poised for growth, Argent BioPharma is now set to emerge as a key player in the biopharmaceutical industry, leveraging cutting-edge advancements in Polypharmacology and Nanotechnology.
  • With its presence on both the London Stock Exchange and the Australian Stock Exchange, Argent BioPharma is well-positioned to make substantial contributions to enhancing medical treatment accessibility.
  • As Argent BioPharma transitions from MGC Pharma, it stands ready to lead a new era in biopharmaceuticals, promising accessible and impactful healthcare solutions on a global scale.

HTuO Biosciences Joins Johnson & Johnson Innovation - JLABS

Retrieved on: 
Monday, February 12, 2024

HTuO Biosciences , a biotechnology company developing an innovative molecular simulation platform for drug discovery, announces it has joined Johnson & Johnson Innovation - JLABS as a resident virtual company.

Key Points: 
  • HTuO Biosciences , a biotechnology company developing an innovative molecular simulation platform for drug discovery, announces it has joined Johnson & Johnson Innovation - JLABS as a resident virtual company.
  • HTuO Biosciences aims to revolutionize drug design and optimization with AtomForge, a platform powered by a proprietary physics engine and machine learning.
  • Dr. Anthony Fejes, CEO and co-founder of HTuO Biosciences, remarks:
    “We are thrilled to join JLABS as it will provide world-class mentorship, industry connections and research capabilities.
  • As a leader in innovation, JLABS helps pharmaceutical, medical technology, and health tech entrepreneurs bring healthcare solutions to patients and consumers.

Global Lipid Nanoparticle Manufacturing Market 2023-2035: Partnerships Surge in Lipid Nanoparticle Manufacturing as Moderna Collaborates with IBM for Cutting-Edge LNPs - ResearchAndMarkets.com

Retrieved on: 
Monday, February 12, 2024

This in turn will drive the market growth of lipid nanoparticle manufacturing market during the forecast period.

Key Points: 
  • This in turn will drive the market growth of lipid nanoparticle manufacturing market during the forecast period.
  • The report features an extensive study of the current market landscape, market size and future opportunities within the lipid nanoparticle manufacturing market, during the given forecast period.
  • Key takeaways of the lipid nanoparticle manufacturing (services and technologies) market report are briefly discussed below.
  • An in-depth analysis of the factors that can impact the growth of lipid nanoparticle manufacturing market.

IOWN Global Forum Unveils Photonics-Driven Future at MWC

Retrieved on: 
Monday, February 12, 2024

At MWC Barcelona this month, the Innovative Optical and Wireless Network Global Forum (IOWN Global Forum) will set out its technology roadmap for 2030, creating a more secure and sustainable world powered by light.

Key Points: 
  • At MWC Barcelona this month, the Innovative Optical and Wireless Network Global Forum (IOWN Global Forum) will set out its technology roadmap for 2030, creating a more secure and sustainable world powered by light.
  • IOWN Global Forum is building a community of best-in-class partners across diverse industries to revolutionize future communication infrastructure, based on leading-edge optical technology and information processing technologies.
  • IOWN Global Forum is now taking its vision to reality with use case level commercialization of its technologies.
  • Dr. Katsuhiko Kawazoe, President and Chairperson of IOWN Global Forum, commented: “IOWN Global Forum is bringing together like-minded companies to create a smarter world that billions of people can experience every day.

Onto Innovation Reports 2023 Fourth Quarter and Full Year Results

Retrieved on: 
Thursday, February 8, 2024

Onto Innovation will host a conference call at 4:30 p.m. Eastern Time today, February 8, 2024, to discuss its fourth quarter and full year 2023 financial results and other matters in greater detail.

Key Points: 
  • Onto Innovation will host a conference call at 4:30 p.m. Eastern Time today, February 8, 2024, to discuss its fourth quarter and full year 2023 financial results and other matters in greater detail.
  • There will be a replay of the conference call available for one year on the Company’s website at www.ontoinnovation.com .
  • As the forward-looking statements are based on Onto Innovation’s current expectations, the Company cannot guarantee any related future results, levels of activity, performance or achievements.
  • Onto Innovation does not assume any obligation to update the forward-looking information contained in this press release, except as required by law.

With More Than 24,000 Registered, SPIE Photonics West 2024 Showcased a Robust and Expanding Industry

Retrieved on: 
Thursday, February 8, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240208158413/en/
    SPIE Photonics West 2024 hosted an enthusiastic crowd of optics and photonics professionals at San Francisco's Moscone Center.
  • (Photo: Business Wire)
    “Photonics West heralds the beginning of the optics and photonics calendar each year for good reason,” said SPIE CEO Kent Rochford.
  • “The invigorating energy and high levels of enthusiasm throughout the Moscone Center characterized a truly exciting week.
  • SPIE Photonics West 2025 will take place 25-30 January at the Moscone Center in San Francisco.

Mile Bluff Medical Center Now Live with MEDITECH Expanse Search and Summarization, Powered by Google Health

Retrieved on: 
Thursday, February 8, 2024

Mile Bluff Medical Center (Mauston, WI) just took a significant step forward in reducing clinician burdens by going live with MEDITECH’s new AI-powered Expanse search and summarization capabilities powered by Google Health.

Key Points: 
  • Mile Bluff Medical Center (Mauston, WI) just took a significant step forward in reducing clinician burdens by going live with MEDITECH’s new AI-powered Expanse search and summarization capabilities powered by Google Health.
  • Mile Bluff’s Expanse EHR uses Google Health’s advanced summarization capabilities to synthesize and organize this data, giving clinicians timely and intuitive access to a more holistic view of patients and their conditions.
  • “Our providers saw an immediate impact upon going live with the search and summarization functionality,” explains Randy Brandt, PA-C, a primary care physician assistant and team lead for the project.
  • “They appreciated how they can launch the functionality directly from their Expanse Chart Viewer to get a complete longitudinal view of their patients.